INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,000 | -22.2% | 16,446 | +3.5% | 0.00% | – |
| Q1 2018 | $9,000 | -30.8% | 15,894 | -2.0% | 0.00% | – |
| Q4 2017 | $13,000 | – | 16,214 | +135016.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 12 | -98.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 596 | -16.2% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 711 | +18.9% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 598 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -98.6% | 598 | -98.7% | 0.00% | – |
| Q2 2016 | $72,000 | +7100.0% | 46,098 | +7608.7% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 598 | -33.5% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 899 | -0.8% | 0.00% | – |
| Q3 2015 | $2,000 | +100.0% | 906 | +195.1% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 307 | -0.3% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 308 | +2.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 302 | +30100.0% | 0.00% | – |
| Q3 2014 | $0 | – | 1 | -98.6% | 0.00% | – |
| Q2 2014 | $0 | – | 69 | +1625.0% | 0.00% | – |
| Q1 2014 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST FOUNDATION ADVISORS | 50,000 | $90,000 | 0.01% |
| FIRST MIDWEST BANK TRUST DIVISION | 16,120 | $29,000 | 0.01% |
| Nine Chapters Capital Management LLC | 12,900 | $23,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,027 | $2,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 12,109 | $22,000 | 0.00% |
| 1832 Asset Management L.P. | 10,012 | $18,000 | 0.00% |
| TORONTO DOMINION BANK | 34 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 117,727 | $213,000 | 0.00% |
| MORGAN STANLEY | 59,700 | $109,000 | 0.00% |